Business Model：

Over the years ParmaSTAR has fruitfully collaborated with many multinational companies. Our experience is extensive in all types of partnerships including third party services, licensing-out, licensing-in, co-development, co-marketing, co-promotion and distributions.

License-in:

PharmaSTAR is kindly looking explore in-licensing opportunities and offers a strong domestic and efficient supply chain infrastructure to partners. We also help our partner conduct clinical trials in Taiwan. Followings are the main advantages of conducting trials in Taiwan:

1. Lowing cost:
   PharmaSTAR shares the cost of local clinical trial, and make sure our clinical trials proceed smoothly.
2. Local Asian people clinical data:
   By conducting trials in Taiwan, multinational drug makers can submit Foreign Clinical Data Complete clinical data package for registration containing clinical data that fulfill the regulatory requirements of the new region and containing pharmacokinetic data relevant to the population in the new region.
3. Facilitate progression of clinical trial:
   PharmaSTAR has good relationship with principle investigators and clinical researchers in all fields.

PharmaSTAR is attractively positioned through its regulatory experience, infrastructure and sales strengths as well as marketing skills to maximize sales for partners through adding your brands to PharmaSTAR's existing portfolio or creating new focused sales teams for promoting complementary products and innovator brands into the country.
We invite you to get in touch with our business development team to explore the manner in which we can grow your brands and products successfully.

For more information please contact CEO Mr. Lyman Lee E-mail:lymanlee@pharmastar.com.tw

Business Development Activities：

• Brand product development and Co-marketing
• Generic product development and marketing
• New formulation development and marketing
• Participate in National R&D projects
• Conduct phase III multi-clinical trial